Thoma Bravo related stories
All articles and analysis
peHUB Wire: Friday, February 26, 2010Bank Buyouts Are Slow But Not Totally Dead
- peHUB Wire: Friday, February 26, 2010
Bank Buyouts Are Slow But Not Totally Dead
- AMICAS to Review Merge's Revised Offer
AMICAS Inc., a publicly traded medical technology company, said it would review the revised offer it received from Merge Healthcare now that it has been updated to include an executed definitive commitment letter for $200 million of financing from Morgan Stanley. AMICAS had previously agreed to sell itself to New York buyout firm Thoma Bravo, rejecting a rival offer from Merge because it did not have proof of guaranteed financing.
- AMICAS Rejects Rival Offer
Nasdaq-listed AMICAS, Inc. an image and information management solutions company, responded Merge Healthcare Inc.'s acquisition proposal. AMICAS Board of Directors has considered and publicly rejected Merge's acquisition proposal, and the company restated its support its previously agreed-upon deal to sell to Thoma Bravo for $217 million.
- peHUB Wire: Tuesday, February 23, 2010
Random Ramblings
- peHUB Wire: Tuesday, February 23, 2010
Random Ramblings
- AMICAS Receives Rival Buyout Offer
AMICAS Inc. (Nasdaq: AMCS), a Boston-based provider of image and information management solutions, said that it has received a $6.05 per share buyout offer from Merge Healthcare Inc. (Nasdaq: MRGE). This tops an existing $5.35 per share bid from private equity firm Thoma Bravo, which would have valued AMICAS at approximately $217 million. Raymond James & Associates is serving as financial advisor to AMICAS.
- peHUB Wire, Monday, February 22, 2010
Random Ramblings
- peHUB Wire, Monday, February 22, 2010
Random Ramblings